Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival

OSBREAC, NBCS Collaborators, NBCS Collaborators, NBCS Collaborators, NBCS Collaborators, NBCS Collaborators, NBCS Collaborators, NBCS Collaborators, NBCS Collaborators, ABCTB Investigators, KConFab investigators, KConFab investigators

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival'. Together they form a unique fingerprint.

Medicine & Life Sciences